Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Peripheral muscle dysfunction in chronic obstructive pulmonary disease].

F Maltais1, P Leblanc, J Jobin

  • 1Institut universitaire de cardiologie et de pneumologie, Hôpital Laval, Université Laval, Québec, Canada.

Revue Des Maladies Respiratoires
|November 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.

Respiratory medicine·2024
Same author

The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

BMC biology·2021
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men.

Calcified tissue international·2019
Same author

Amyotrophic lateral sclerosis in Huntington disease gene carrier.

Revue neurologique·2017
Same author

Ethno-Cultural Considerations in Cardiac Patients' Medication Adherence.

Clinical nursing research·2016
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Patients with chronic obstructive pulmonary disease (COPD) experience peripheral muscle dysfunction, leading to weakness and reduced exercise capacity. This review discusses the implications and therapeutic strategies for improving muscle function in COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Exercise Physiology
  • Muscle Biology

Context:

  • Chronic obstructive pulmonary disease (COPD) frequently causes systemic complications beyond lung impairment.
  • Peripheral muscle dysfunction, marked by atrophy, weakness, and reduced oxidative capacity, is a significant complication in COPD patients.
  • These muscle alterations impact exercise tolerance and quality of life independently of respiratory function.

Purpose:

  • To review the evidence supporting peripheral muscle dysfunction in COPD.
  • To discuss the clinical implications of muscle dysfunction in COPD.
  • To examine current therapeutic options for enhancing peripheral muscle function in COPD.

Summary:

  • Peripheral muscle dysfunction is a common systemic complication in COPD, characterized by atrophy, weakness, and low oxidative capacity.

Related Experiment Videos

  • These changes significantly affect exercise tolerance and quality of life, irrespective of lung function.
  • The article explores the evidence, clinical relevance, and treatment strategies for this condition.
  • Impact:

    • Highlights the importance of addressing peripheral muscle dysfunction in COPD management.
    • Informs clinicians about the systemic effects of COPD on skeletal muscles.
    • Provides an overview of potential interventions to improve muscle health and patient outcomes in COPD.